Skip to content

Next Generation CT System

Clinical Feasibility and Evaluation of Silicon Photon Counting CT

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06769594
Enrollment
64
Registered
2025-01-10
Start date
2025-04-08
Completion date
2026-03-06
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Computed Tomography

Brief summary

The purpose of the study is to collect data to evaluate utility of a next generation CT system in a clinical setting.

Detailed description

Data collected in this study includes an assessment of image quality parameters including spatial resolution, image contrast, and noise to evaluate the product. This data and analysis will help support regulatory submission.

Interventions

DEVICEInvestigational CT Scan

All pre-contrast testing and administration of supporting medications shall be done according to the hospital's SOC. Images will then be compared with the previously acquired imaging conducted as standard of care. The investigational scan takes between 10-30 minutes.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY
University of Wisconsin, Madison
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects may be included in this study if they meet the following criteria: 1. Who are 18 year of age or older; 2. Able to sign and date the informed consent form; AND 3. Who have in the past 120 days or will in the future 30 days from the day of consent undergo a clinically indicated imaging exam (MRI, CT, radiograph, nuclear medicine, ultrasound, bone material density, interventional radiology procedure) of the head, neck, heart, chest, abdomen, pelvis, or extremities where images are available for this prior exam.

Exclusion criteria

Subjects may be excluded from participating in study if they meet any of the following criteria: 1. Who are pregnant or lactating; 2. Who were previously enrolled in this study; 3. For contrast-enhanced CT exams, anyone with known or suspected allergy to iodinated contrast agents; 4. For contrast-enhanced CT exams, anyone with known or suspected renal insufficiency as determined by site medical personnel; 5. Who are in need of urgent or emergent care; 6. Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; and, 7. Who are unwilling to have GEHC personnel present for the CT exam.

Design outcomes

Primary

MeasureTime frameDescription
Data Collection12 monthsNumber of investigational CT scans along with standard of care CT images

Secondary

MeasureTime frameDescription
Safety Information12 monthsType and numbers of AEs, SAEs, and Device Deficiencies
Assessment of Image Quality12 monthsImages created from the raw investigational CT scan data will be scored for image quality

Countries

United States

Contacts

STUDY_DIRECTORMICT Global Research Manager

GE Healthcare

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026